EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?

Meg Schuurman, Jonathan Nguyen, Malina Barillaro iD, Nica Borradaile, Rennian Wang iD

Endocrinology · 29.09.2026 · 167 (11)

DOI: 10.1210/endocr/bqag114 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 10.10.2026. Verfasst von Meg Schuurman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Health Research Institute, University of Western Ontario, London, ON N6C 2V5, Canada. Hauptthemen laut MEDLINE: Acetylcysteine, Insulin-Secreting Cells, Antioxidants. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-acetyl-L-cysteine (NAC) is a widely used antioxidant with increasing public interest in its use for treating metabolic disease, yet its effects on pancreatic β cells remain incompletely understood. Most studies focus on NAC's benefits under pathological conditions—such as obesity, high-fat diet exposure, and type 2 diabetes—where oxidative stress impairs β-cell function, identity, and survival. In these contexts, NAC can reduce oxidative damage, preserve insulin secretion, and limit islet fibrosis. However, far fewer studies examine NAC under normal physiological or aging conditions, where moderate reactive oxygen species levels are required for β-cell signaling and glucose-stimulated insulin secretion. Emerging evidence shows that excessive antioxidant exposure during non-pathological states may disrupt redox-dependent pathways, suppress insulin biosynthesis and exocytosis, and contribute to reductive stress. Here, we review the current evidence of NAC's impact on β cells across physiological, aging, and pathological settings. Moreover, we highlight that NAC can be protective or detrimental depending on redox state, metabolic environment, and dosing, which emphasizes the need for careful consideration of antioxidant use in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineInsulin-Secreting CellsAntioxidantsHumansAnimalsOxidative StressReactive Oxygen SpeciesInsulinInsulin SecretionDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

N-acetyl-L-cysteineROS balanceantioxidantsinsulin secretionβ cell

Substanzen

AcetylcysteineAntioxidantsReactive Oxygen SpeciesInsulin

Autor:innen und Institutionen

  • Children's Health Research Institute, University of Western Ontario, London, ON N6C 2V5, Canada.
  • Department of Physiology & Pharmacology, University of Western Ontario, London, ON N6A 5C1, Canada.
  • Department of Medicine, University of Western Ontario, London, ON N6A 5C1, Canada.

ORCID-Profile: Malina Barillaro, Rennian Wang

Förderung

  • Canadian Institute of Health Research

Zitieren

APA

Schuurman, M., Nguyen, J., Barillaro, M., Borradaile, N., & Wang, R. (2026). Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?. Endocrinology, 167(11). https://doi.org/10.1210/endocr/bqag114

Vancouver

Schuurman M, Nguyen J, Barillaro M, Borradaile N, Wang R. Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?. Endocrinology. 2026;167(11). doi:10.1210/endocr/bqag114

BibTeX
@article{Schuurman2026,
  author = {Schuurman, Meg and Nguyen, Jonathan and Barillaro, Malina and Borradaile, Nica and Wang, Rennian},
  title = {Antioxidant therapy, N-acetyl-L-cysteine, effects on pancreatic β cells: therapeutic promise or potential harm?},
  journal = {Endocrinology},
  year = {2026},
  volume = {167},
  number = {11},
  doi = {10.1210/endocr/bqag114}
}
Kostenlos starten →